Feedback PLC (AIM:FDBK), the remote diagnostics specialist, has said its trading in the six months to 30 November 2022 was in line with the board's and market's expectations.
Revenue for the period is expected to be £0.6mln, up approximately 200% on a year earlier, and boosted by the extension of its Community Diagnostic Centre (CDC) contract in Sussex. That is a £0.5mln contract covering the 12-month period from 31 March 2022.
Feedback reiterated that the CDC programme in the NHS is driving interest in its Bleepa-CareLocker suite of mobile-based diagnostic tools.
These remain a core opportunity, it added, and the Sussex CDC pilot has given credibility to both the Bleepa-CareLocker platform and the symptom-based pathway approach.
The UK government's commitment is to fund 160 CDCs across the UK, and Feedback said it remains in conversations with OEMs and other commercial entities around potential joint go-to-market strategies to meet this opportunity.
Elsewhere, Feedback noted that the CareLocker consumer app developed in conjunction with Sampurna in India is also moving towards the pilot programme stage.
Cash and cash equivalents on 30 November 2022 were around £9.2mln (30 November 2021: £11.4mln), the company said in the half-year trading update.